More Articles

After patients suffer a stroke, their rehabilitation program should include input and coordination from physicians, nurses, family members, therapists, psychologists and others, according to new guidelines from the American Heart Association (AHA…

Cardinal Health announced on May 12 that it had reached a distribution agreement to sell Biosensors’ coronary stents in Europe, the Middle East, Africa, Australia and New Zealand.

Cordis, Cardinal Health’s interventional vascular business,…

Business 101 says you should always get what you pay for. But according a new article in the Wall Street Journal, health insurers are trying to flip the equation, paying for what they—or, more precisely, their patients—get.

Cigna…

Cook Medical voluntarily recalled all lots of catheters with its Beacon Tip technology.

The recall includes…

April 25, 2016 | Vascular & Endovascular

A real-world study found that the Reveal LINQ insertable cardiac monitor had an atrial fibrillation detection rate of 16.3 percent, which was a 32 percent relative increase compared with the rate found in a previous randomized, controlled…

April 21, 2016 | Vascular & Endovascular

Auris Surgical Robotics agreed on April 20 to acquire Hansen Medical for approximately $80 million.

Auris Surgical will pay…

April 21, 2016 | Vascular & Endovascular

A retrospective database claims analysis found that adults with nonvalvular atrial fibrillation who received rivaroxaban (Xarelto) had a statistically significant 47 percent reduction in intracranial hemorrhage and non-statistically significant…

Tim Casey
April 19, 2016 | Vascular & Endovascular

As part of the Centers for Medicaid & Medicare Services (CMS) value-based purchasing program, more than 3,500 hospitals report their 30-day mortality rates and other measures. The hospitals are paid in part based on the quality of care they…

April 15, 2016 | Vascular & Endovascular

Patients with acute stroke who were transferred to a hospital participating in a stroke registry in Michigan had significantly higher rates of in-hospital mortality and in-hospital complications compared with those who were not transferred.

April 11, 2016 | Vascular & Endovascular

Vascular Solutions voluntarily recalled specific lots of its Guardian II hemostasis valves, which are used in catheterization procedures.

The FDA classified the…

April 04, 2016 | Vascular & Endovascular

Malnourishment remains a challenge in some of the world’s poorest regions, yet, if current trends continue, by 2025 more than 21 percent of the world’s women and 18 percent of men will be obese.

Moreover, some 9 percent of women and 6…

March 24, 2016 | Vascular & Endovascular

Since the beginning of the year, eight facilities have met the Centers for Medicare & Medicaid Services’ (CMS’) minimum facility standards for performing carotid artery stenting for high risk patients.

The facilities…

March 18, 2016 | Vascular & Endovascular

An analysis of a quality improvement registry of patients with atrial fibrillation found that a one-point increase in the CHADS2 score or the CHA2DS2-VASc score was associated with an approximately 15 percent…

March 18, 2016 | Vascular & Endovascular

Since 2002, the FDA has received more than 9,000 reports of malfunctions with the INRatio and INRatio2 blood testing devices, the New York Times reports. The devices are used to help manage patients who are taking warfarin. The newspaper…

Tim Casey
March 16, 2016 | Vascular & Endovascular

As the healthcare industry undergoes massive change, hospitals and health systems are attempting to adapt to the pressures associated with keeping costs down while providing high quality care. They are seeking alternative, creative ways to…

March 07, 2016 | Vascular & Endovascular

ReCor Medical announced the FDA had granted the company an investigational device exemption approval for a trial to evaluate the effect of the ReCor Paradise Renal Denervation System on blood pressure in patients with hypertension.

The…

March 03, 2016 | Vascular & Endovascular

Despite the increasing prevalence of peripheral artery disease (PAD) around the world (Lancet 2013;382:1329-1340), the impact of PAD on survival and quality of life (Glob Heart 2014;9:145-158) and the expanding prevalence and impact of venous…

February 23, 2016 | Vascular & Endovascular

During a five-year follow-up period, asymptomatic patients with severe carotid stenosis had similar rates of stroke and survival whether they underwent carotid artery stenting with embolic protection or carotid endarterectomy.

The…

February 22, 2016 | Vascular & Endovascular

After a median follow-up period of nearly five years, patients who received pioglitazone following a recent ischemic stroke or transient ischemic attack (TIA) had a lower risk of stroke or MI compared with a placebo group, according to a…

February 19, 2016 | Vascular & Endovascular

People with untreated hypertension have a nine-fold higher risk of having an intracerebral hemorrhage regardless of race compared with those who are receiving treatment, according to a prospective, multicenter, case-control study.

Lead…

physician payment concept image
February 19, 2016 | Vascular & Endovascular

During the past decade, the cost of alteplase increased 111 percent, although reimbursement to hospitals for the clot-busting medication increased only 8 percent, according to an analysis.

Lead researcher Dawn Kleindorfer, MD, FAHA,…

Trimed Popup
Trimed Popup